ATC code None Synonyms ACH-1625 PubChem CID 53362096 Molar mass 799.98 g/mol ChemSpider ID 28529313 | Legal status Investigational CAS Number 1001667-23-7 UNII 2ND9V3MN6O Pubchem 53362096 | |
 | ||
Sovaprevir (codenamed ACH-1625) is an experimental drug designed to treat the hepatitis C virus. It is under development by Achillion Pharmaceuticals. It acts as a NS3/4A inhibitor.
Sovaprevir received Fast Track status from the U.S. Food and Drug Administration (FDA) in 2012.
References
Sovaprevir Wikipedia(Text) CC BY-SA